[go: up one dir, main page]

FI964681A0 - Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt - Google Patents

Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt

Info

Publication number
FI964681A0
FI964681A0 FI964681A FI964681A FI964681A0 FI 964681 A0 FI964681 A0 FI 964681A0 FI 964681 A FI964681 A FI 964681A FI 964681 A FI964681 A FI 964681A FI 964681 A0 FI964681 A0 FI 964681A0
Authority
FI
Finland
Prior art keywords
compositions
lactobacillus strains
human origin
lactobacillus
strains
Prior art date
Application number
FI964681A
Other languages
English (en)
Swedish (sv)
Other versions
FI119059B (fi
FI964681L (fi
Inventor
Lorenzo Morelli
Vittorio Bottazzi
Luigia Gozzini
Haen Christoph De
Original Assignee
Bracco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26331139&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI964681(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ITMI941073A external-priority patent/IT1269838B/it
Priority claimed from ITMI941773A external-priority patent/IT1274733B/it
Application filed by Bracco Spa filed Critical Bracco Spa
Publication of FI964681A0 publication Critical patent/FI964681A0/fi
Publication of FI964681L publication Critical patent/FI964681L/fi
Application granted granted Critical
Publication of FI119059B publication Critical patent/FI119059B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
FI964681A 1994-05-26 1996-11-25 Ihmisestä peräisin olevat Lactobacillus-kannat, niiden koostumukset ja niiden käytöt FI119059B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
ITMI941073 1994-05-26
ITMI941073A IT1269838B (it) 1994-05-26 1994-05-26 Ceppi di lattobacilli di origine umana e loro usi
ITMI941773A IT1274733B (it) 1994-08-25 1994-08-25 Ceppo del genere lactobacillus di origine umana e suoi usi
ITMI941773 1994-08-25
EP9501886 1995-05-18
PCT/EP1995/001886 WO1995033046A1 (en) 1994-05-26 1995-05-18 Lactobacillus strains of human origin, their compositions and uses thereof

Publications (3)

Publication Number Publication Date
FI964681A0 true FI964681A0 (fi) 1996-11-25
FI964681L FI964681L (fi) 1997-01-08
FI119059B FI119059B (fi) 2008-07-15

Family

ID=26331139

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964681A FI119059B (fi) 1994-05-26 1996-11-25 Ihmisestä peräisin olevat Lactobacillus-kannat, niiden koostumukset ja niiden käytöt

Country Status (18)

Country Link
US (1) US5709857A (fi)
EP (1) EP0760848B1 (fi)
JP (1) JP3653277B2 (fi)
CN (1) CN1094972C (fi)
AT (1) ATE163042T1 (fi)
AU (1) AU686389B2 (fi)
BR (1) BR9507752A (fi)
CA (1) CA2191213C (fi)
DE (2) DE760848T1 (fi)
DK (1) DK0760848T3 (fi)
ES (1) ES2099056T3 (fi)
FI (1) FI119059B (fi)
GR (2) GR970300016T1 (fi)
HU (1) HU220190B (fi)
MX (1) MX9605807A (fi)
NO (1) NO316644B1 (fi)
NZ (1) NZ287420A (fi)
WO (1) WO1995033046A1 (fi)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN175495A0 (en) 1995-03-14 1995-04-13 University Of New England, The Method and composition for the prevention of the over production of acid
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
IT1289159B1 (it) * 1997-01-08 1998-09-29 Yurta S R L Composizioni farmaceutiche e alimentari a base di batteri del genere acetobacter
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
IT1299070B1 (it) * 1998-04-10 2000-02-07 Proge Farm Srl Ceppi di lattobacilli capaci di inibire e/o avere azione microbicida nei confronti di microorganismi patogeni e metodo di induzione e
US7202219B1 (en) * 1998-02-24 2007-04-10 Md Foods Amba Use of D-tagatose as a prebiotic food component
DE69802260T2 (de) 1998-04-30 2002-07-04 Renata Maria Anna Cavaliere Vesely Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
MXPA01009017A (es) * 1999-03-11 2002-04-24 Nestle Sa Cepas de lactobacillus capaces de evitar diarrea causada por bacterias patogenicas y rotavirus.
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
US20040105848A1 (en) * 1999-04-30 2004-06-03 Natarajan Ranganathan Enteric dialysis compositions and methods
US6641808B1 (en) 1999-09-22 2003-11-04 Lacpro Industries, Llc Composition for treatment of obesity
US6696057B1 (en) 1999-09-22 2004-02-24 Lacpro Industries, Inc. Composition and method for treatment of gastrointestinal disorders and hyperlipidemia
US20040166101A1 (en) * 1999-09-22 2004-08-26 Bojrab Gregory G. Enchanced composition for treatment of gastrointestinal disorders and hyperlipidemia
US6613549B2 (en) 2000-02-10 2003-09-02 Urex Biotech, Inc. Probiotic therapy for newborns
CA2411944C (en) * 2000-06-09 2010-12-14 Baylor College Of Medicine The combination of antimicrobial agents and bacterial interference to coat medical devices
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US6797266B2 (en) 2000-12-18 2004-09-28 Probiohealth Probiotic composition containing Lactobacillus casei strain ATCC PTA-3945
US7214370B2 (en) * 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
US7060687B2 (en) * 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
NO318426B1 (no) * 2001-10-02 2005-04-18 Neurozym Biotech As Et materiale for a senke konsentrasjonen av patogene tarmpeptider
US8147821B2 (en) 2002-02-21 2012-04-03 Grain Processing Corporation Method for drying biomaterials
PT1485463E (pt) 2002-03-21 2008-12-30 Bifodan As Estirpes de lactobacillus
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
US8479409B2 (en) 2005-05-16 2013-07-09 Grain Processing Corporation Method for drying spent filter media
CN101273736B (zh) * 2007-03-28 2012-08-08 北京弗蒙特生物技术有限公司 一种在常温下保持高活菌数的发酵乳的制备方法
ES2333479T3 (es) * 2007-07-13 2010-02-22 Unilever N.V. Producto alimenticio que comprende bacterias y acido graso de sorbitano.
US20090041727A1 (en) * 2007-08-08 2009-02-12 Conjugon, Inc. Compositions and Methods for Microbe Storage and Delivery
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
US20110189148A1 (en) * 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
KR101003149B1 (ko) * 2008-10-31 2010-12-22 전남대학교산학협력단 병변 치료용 박테리아 기반의 마이크로로봇
EP2206506A1 (en) 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
KR20110124780A (ko) 2009-02-24 2011-11-17 리터 파마슈티컬즈 인코오포레이티드 프리바이오틱 제제 및 사용 방법
EP2248908A1 (en) 2009-05-05 2010-11-10 Eurolactis Group S.A. Probiotic microorganisms isolated from donkey milk
US20120087902A1 (en) * 2009-07-20 2012-04-12 Bracco S.P.A. Therapeutic Use Of Probiotics
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
KR20130098320A (ko) 2010-08-04 2013-09-04 토마스 줄리어스 보로디 분변 세균총 이식을 위한 조성물, 그의 제조 방법과 사용 방법, 및 그를 전달하기 위한 장치
CN103561752B (zh) 2011-03-09 2016-04-20 明尼苏达大学评议会 用于移植结肠微生物群的组合物和方法
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
CN105283191A (zh) * 2012-09-25 2016-01-27 阿曲龙Cyl有限公司 益生菌和益生元组合物
KR102561989B1 (ko) 2015-05-14 2023-07-31 핀치 테라퓨틱스 홀딩스 엘엘씨 대변 균무리 이식용 조성물, 및 이의 제조 및 사용 방법, 및 이의 전달을 위한 장치
KR102358879B1 (ko) 2015-05-22 2022-02-08 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 자폐 스펙트럼 장애 및 관련된 증상을 치료하는 방법
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
EP3606541A1 (en) 2017-04-05 2020-02-12 Crestovo Holdings LLC Compositions and methods for treating parkinson's disease (pd) and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
EP3630190B1 (en) 2017-05-26 2024-02-21 Finch Therapeutics Holdings LLC Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
CA3072032A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
KR20210065969A (ko) 2018-09-27 2021-06-04 핀치 테라퓨틱스 홀딩스 엘엘씨 간질 및 관련 장애를 치료하기 위한 조성물 및 방법
PE20221399A1 (es) 2019-07-19 2022-09-15 Finch Therapeutics Holdings Llc Metodos y productos para el tratamiento de trastornos gastrointestinales

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US4946791A (en) * 1986-10-02 1990-08-07 Bio Techniques Laboratories, Inc. Novel strain of Lactobacillus acidophilus
US5179020A (en) * 1991-08-19 1993-01-12 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
ES2102485T3 (es) * 1992-07-06 1997-08-01 Nestle Sa Bacteria lactica.

Also Published As

Publication number Publication date
DE69501591D1 (de) 1998-03-12
NO964966L (no) 1997-01-23
JP3653277B2 (ja) 2005-05-25
DK0760848T3 (da) 1998-09-23
FI119059B (fi) 2008-07-15
ES2099056T1 (es) 1997-05-16
HU9603251D0 (en) 1997-01-28
NZ287420A (en) 1997-12-19
DE760848T1 (de) 1997-08-28
ES2099056T3 (es) 1998-04-01
CA2191213A1 (en) 1995-12-07
AU686389B2 (en) 1998-02-05
US5709857A (en) 1998-01-20
DE69501591T2 (de) 1998-06-10
CA2191213C (en) 2008-03-18
GR970300016T1 (en) 1997-05-31
WO1995033046A1 (en) 1995-12-07
EP0760848A1 (en) 1997-03-12
GR3026758T3 (en) 1998-07-31
NO964966D0 (no) 1996-11-22
CN1094972C (zh) 2002-11-27
NO316644B1 (no) 2004-03-22
ATE163042T1 (de) 1998-02-15
CN1154715A (zh) 1997-07-16
FI964681L (fi) 1997-01-08
MX9605807A (es) 1997-12-31
BR9507752A (pt) 1997-10-07
HU220190B (hu) 2001-11-28
JPH10500577A (ja) 1998-01-20
AU2613995A (en) 1995-12-21
EP0760848B1 (en) 1998-02-04
HUT75555A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
DE69729786D1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
BG102781A (en) Isolated dimer fibroblastactivation protein alpha and its application
DE69905170D1 (en) Thiazolopyrimidinderivate
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
MX9601994A (es) Profarmacos de derivados de paclitaxel.
DE69616074D1 (de) Ara-c derivate
BG102667A (en) Diosgenine-containing composition
BG100248A (bg) Инхибитори на скваленсинтетаза
AU6849198A (en) Neurotrypsin
FI944563A0 (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
DK1011329T3 (da) 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler
MD980129A (en) Antiherpetic remedy
BR9611904A (pt) Dioxidos de ditiazol
FR2707492B1 (fr) Nouvelles compositions cosmétiques ou dermatologiques renfermant les ribosomes, préparation des ribosomes, préparation desdites compositions et leur application.
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.
UA30250A (uk) Антиоксидантний засіб

Legal Events

Date Code Title Description
MM Patent lapsed